Janumet® (Sitagliptin + Metformin)
Dual-action oral diabetes medication combining Sitagliptin and Metformin to help improve blood sugar control in adults with type 2 diabetes.
| BRAND Products | Your Price | |
|---|---|---|
| $80.00 | |
| $85.00 | |
| $70.00 | |
| $80.00 | |
| GENERIC Products | Your Price | |
|---|---|---|
| $80.00 | |
Janumet® (Sitagliptin + Metformin) — Product Details
Janumet® (Sitagliptin + Metformin) is a prescription oral medication designed to improve blood sugar levels in adults with type 2 diabetes. It combines two powerful antidiabetic agents in a single tablet to target different aspects of glucose regulation.
- Sitagliptin: A DPP-4 inhibitor that increases insulin production and decreases glucose production in the liver, particularly after meals.
- Metformin: A biguanide that lowers glucose production in the liver and improves the body’s sensitivity to insulin.
This dual-action combination is ideal for patients who require additional glycemic control beyond Metformin alone. Janumet helps manage A1C levels and supports long-term diabetic care when combined with a healthy diet and regular exercise.
It is not intended for treating type 1 diabetes or diabetic ketoacidosis. Regular monitoring of kidney function and vitamin B12 levels is advised during treatment. Always follow your healthcare provider's instructions when using Janumet.
Key Benefits
- Combines two proven medications in one convenient tablet
- Improves glycemic control more effectively than Metformin alone
- Reduces post-meal and fasting blood glucose levels
- Helps maintain A1C targets in type 2 diabetes
- Once or twice daily dosing as prescribed
| Med Type Both | 1 |
|---|---|
| Rx Req | 1 |
| Top Seller | 1 |